乳房病変ローカリゼーションの世界市場2022-2027

• 英文タイトル:Breast Lesion Localization Methods Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Breast Lesion Localization Methods Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)「乳房病変ローカリゼーションの世界市場2022-2027」(市場規模、市場予測)調査レポートです。• レポートコード:MRC2203A052
• 出版社/出版日:Mordor Intelligence / 2022年1月
• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥612,750 (USD4,750)▷ お問い合わせ
  Site Licence¥838,500 (USD6,500)▷ お問い合わせ
  Corporate License¥1,128,750 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Mordor Intelligence社は、世界の乳房病変ローカリゼーション市場規模が、年平均11.2%成長すると予測しています。本市場調査レポートでは、乳房病変ローカリゼーションの世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、種類別(ワイヤーローカリゼーション、放射性同位元素ローカリゼーション、磁気トレーサーローカリゼーション、その他ローカリゼーション)分析、地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の乳房病変ローカリゼーション市場規模:種類別(ワイヤーローカリゼーション、放射性同位元素ローカリゼーション、磁気トレーサーローカリゼーション、その他ローカリゼーション)
・世界の乳房病変ローカリゼーション市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米)
・競争状況(Becton Dickinson、SOMATEX Medical Technologies、Cook Medical、…)
・市場機会・将来傾向

The Breast Lesion Localization Methods Market is expected to register a CAGR of 11.2% during the forecast period. Breast lesion is an abnormal change of the breast tissue which is caused by diseases or injuries. For earlier detection of breast lesions, localization procedures have become necessary in up to 50% of all lumpectomy and surgical biopsy procedures to ensure accurate removal of the target lesion. Breast cancer is the most common type of cancer among women worldwide. According to Breast Cancer Organization, it was estimated that 266,120 new cases of invasive and 63,960 cases of non-invasive breast cancer were diagnosed in the year 2018. According to World Health Organization (WHO), breast cancer is the most frequent type of cancer among women globally, approximately 2.1 million women suffer from breast cancer every year, and with the highest number of cancer-related deaths among women. Increasing prevalence of breast cancer and expanding breast cancer surgeries, technological advancements in breast lesion localization and increasing awareness of early detection of breast cancer are the key driving factors in breast cancer liquid biopsy market.

Key Market Trends

Wire Localization Segment is Expected to Hold a Major Market Share in the Breast Lesion Localization Methods Market

  • A wire localization biopsy is a procedure used to mark or identify the exact location of a lump or abnormality by using fine wire. Localization biopsy is done before a surgeon does an excisional biopsy to remove the lump.
  • According to World Health Organization (WHO), in the year 2018, it was estimated that approximately 627,000 women died from breast cancer that is nearly 15% of all cancer deaths among women globally.
  • Wire Localization segment hold a significant market share in the breast cancer liquid biopsy market and is anticipated to show similar trend over the forecast period.
  • Increasing prevalence of breast cancer, expanding breast cancer surgeries and technological advancements are the key driving factors in the Wire Localization segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global breast lesion localization methods market due to increasing prevalence of breast cancer and expanding breast cancer surgeries and increasing awareness of early detection of breast cancer in this region. According to the National Breast Cancer Foundation, in the year 2019, 62% of breast cancer cases were diagnosed at a localized stage. Female breast cancer represents approximately 15.2% of all new cancer cases in the United States. Furthermore, the high adoption of technological advancements in breast lesion localization and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Breast Lesion Localization Methods Market is consolidated competitive and consists of few major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Becton Dickinson, SOMATEX Medical Technologies, Cook Medical, Cianna Medical, STERYLAB S.r.l, Leica Biosystems, CP Medical, Inc, Elucent Medical, Tsunami S.r.l and M.D.L. srl.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
レポート目次

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Breast Cancer And Expanding Breast Cancer Surgeries
4.2.2 Technological Advancements In Breast Lesion Localization
4.2.3 Increasing Awareness of Early Detection of Breast Cancer
4.3 Market Restraints
4.3.1 High Cost Associated with Breast Lesion Localization Methods
4.3.2 Stringent Regulatory Requirements
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Type
5.1.1 Wire Localization
5.1.2 Radioisotope Localization
5.1.3 Magnetic Tracers Localization
5.1.4 Other Localization Methods
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton Dickinson
6.1.2 SOMATEX Medical Technologies
6.1.3 Cook Medical
6.1.4 Cianna Medical
6.1.5 STERYLAB S.r.l
6.1.6 Leica Biosystems
6.1.7 CP Medical, Inc
6.1.8 Elucent Medical
6.1.9 Tsunami S.r.l
6.1.10 M.D.L. srl

7 MARKET OPPORTUNITIES AND FUTURE TRENDS




• 英文レポート名:Breast Lesion Localization Methods Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
• 日本語訳:乳房病変ローカリゼーションの世界市場2022-2027
• レポートコード:MRC2203A052お問い合わせ(見積依頼・ご注文・質問)